Enlightening a Novel Dimension- Mifepristone in Pre-Induction Cervical Ripening in Term Pregnancy

Journal Title: Indian Journal of Obstetrics and Gynecology - Year 2017, Vol 5, Issue 1

Abstract

Introduction: Mifepristone is a 19- nor steroid that binds to the progesterone receptor and inhibits the activity of progesterone at cellular level. It ripens cervix with minimal effect on uterine contractility, favouring pre-induction cervical ripening to enhance the rate of spontaneous labour without apparent maternal and neonatal side effects. Aims and Objectives: • To determine the efficacy and safety of Mifepristone to prime the cervix and induce labour at term. • To compare the effect of Mifepristone with placebo on cervical ripening before labour induction in term pregnancy. Material and Methods: 100 patients with singleton pregnancy of 37-42 weeks with Modified Bishop’s score  5 were included in the study after their informed consent. Exclusion Criteria: Cephalopelvic disproportion • Previous LSCS • Hypersensitivity to Prostaglandins and Mifepristone Patients were given either oral Tablet Mifepristone 200mg (n=50) or Placebo (n=50) after assessing Modified Bishop’s score. Change in Modified Bishop’s score is assessed after 24 hrs and 48 hrs. Even after 48 hrs if labour had not begun or Modified Bishop’s score  5 induction with Prostaglandin E2 0.5mg gel or Prostaglandin E1 tablet 25 µg done. Results: Out of 100 patients, 29 patients entered spontaneous labour within 48 hrs, of which 19 were treated with Mifepristone (38%) & 10 with placebo-(20%). 9 of Mifepristone treated (18%) & 3 of placebo treated (6%) patients required only oxytocin for labour augmentation. 59 patients required Prostaglandins for induction, of which 22 were Mifepristone treated (44%) & 37 Placebo treated (74%). Mifepristone treated patients had 72% vaginal delivery rate with reduced induction-delivery interval while it was 46% with placebo. Cesarean rate was 14% in those treated with Mifepristone while 42% with placebo. There was no statistical difference in instrumental delivery. There was no significant difference in intrapartum uterine contractile abnormality and fetal heart rate pattern. There was no significant difference in neonatal outcome measured by APGAR score and NICU admission. Conclusion: Mifepristone is safe & efficient in cervical ripening and initiation of labour at term with increased chance of vaginal delivery in 48hrs.In this era of high primary cesarean rates, Mifepristone provides a new milestone to enhance vaginal delivery rates with safe maternal and neonatal outcome. Theme: “Let Mifepristone unveil the curtains to a new era with drastically decreased primary cesarean rates”

Authors and Affiliations

Mahendra G

Keywords

Related Articles

Association between Vitamin-D Status and Cardiovascular Risk among Postmenopausal Women in Kerala Population

Introduction: cardiovascular diseases (CVD) are the leading cause of morbidity and mortality across the world. Postmenopausal women may have an increased risk of CVD. Vitamin-D (Vit-D) is believed to have an important ro...

Role of Colour Doppler in Intra Uterine Growth Retardation and Its Managemen

Intra uterine growth retardation (IUGR) due to fetoplacental vascular insufficiency is rampant in developing countries like India. Owing to the lack of awareness, antenatal patients often present in their third trimester...

Hysterectomy in the Intellectually Disabled Girl – From the Perspective of Indian Mothers

Introduction: The practice of hysterectomy in intellectually disabled individuals has raised a lot of controversy in both the medical fraternity and the general public. The request comes from the primary caregivers mostl...

A Study to Compare the Maternal and Fetal Outcome in Term Singleton Pregnancies Having AFI < 8CM to those having AFI 8.1-20 CM.

Background and Purpose: Over many decades, studies have been conducted in various parts of the world in an attempt to correlate the AFI with fetal and maternal outcome. Recent studies, however, have challenged the relati...

Analysis of Semen Parameters in Male Partners of Infertile Couples

Approximately 10-15% of couples suffer from infertility all over the world and male factor is responsible in 45%of cases. Determining the possible etiology of male infertility is very important. The aim of this study was...

Download PDF file
  • EP ID EP456810
  • DOI 10.21088/ijog.2321.1636.5117.9
  • Views 103
  • Downloads 0

How To Cite

Mahendra G (2017). Enlightening a Novel Dimension- Mifepristone in Pre-Induction Cervical Ripening in Term Pregnancy. Indian Journal of Obstetrics and Gynecology, 5(1), 55-61. https://europub.co.uk/articles/-A-456810